论文部分内容阅读
目的探讨美多巴联合脑得生治疗帕金森综合征的临床效果。方法选取都安县人民医院诊治的58例帕金森综合征患者,将58例患者随机分为两组,首先给予所有患者常规治疗,在此基础上,观察组患者采用美多巴联合脑得生进行治疗,对照组患者则采用单纯的美多巴进行治疗,对观察组和对照组患者的治疗过程进行跟踪观察,并将所得实验数据记录。结果通过治疗,观察组治疗有效率为93.1%,对照组治疗有效率为75.9%。结论在治疗帕金森综合征疾病的过程中,采用美多巴联合脑得生治疗的效果较为显著,对于患者的帮助较大,值得在临床上推广应用。
Objective To investigate the clinical effect of combined treatment of Parkinson’s Syndrome with Madopar. Methods Fifty-eight patients with Parkinson’s disease who were diagnosed and treated in Du’an People’s Hospital were enrolled. Fifty-eight patients were randomly divided into two groups. First, all patients were given routine treatment. On the basis of this, Treatment, the control group of patients treated with meclopaedic alone, the observation group and the control group were followed up the course of treatment, and the experimental data obtained. Results Through the treatment, the observation group, the effective rate was 93.1%, the control group, the effective rate was 75.9%. Conclusions In the treatment of Parkinson’s disease, the effect of combined treatment of brain with Madopar is more significant, which is of great help to patients and is worth popularizing in clinic.